RenovoRx Inc(RNXT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RNXT RenovoRx Inc

Market Closed 08-14 16:00:00 EDT

1.40

+0.14

+11.11%

盘后1.41

+0.01+0.70%

19:55 EDT

High1.45	Low1.26	Vol1.01M
Open1.27	D1 Closing1.26	Amplitude15.08%
Mkt Cap63.07M	Tradable Cap54.84M	Total Shares45.05M
T/O1.40M	T/O Rate2.57%	Tradable Shares39.17M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RNXT","market":"US","secType":"STK","nameCN":"RenovoRx Inc","latestPrice":1.4,"timestamp":1786737600000,"preClose":1.26,"halted":0,"volume":1007048,"hourTrading":{"tag":"盘后","latestPrice":1.4098,"preClose":1.4,"latestTime":"19:55 EDT","volume":30774,"amount":43458.8189,"timestamp":1786751727164,"change":0.0098,"changeRate":0.007,"amplitude":0.035643},"delay":0,"changeRate":0.11111111111111104,"floatShares":39171100,"shares":45052700,"eps":-0.331663,"marketStatus":"Market Closed","change":0.14,"latestTime":"08-14 16:00:00 EDT","open":1.27,"high":1.45,"low":1.26,"amount":1400594.7048352,"amplitude":0.150794,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.331663,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1786953600000},"marketStatusCode":7,"adr":0,"listingDate":1629950400000,"exchange":"NASDAQ","adjPreClose":1.26,"preHourTrading":{"tag":"盘前","latestPrice":1.27,"preClose":1.26,"latestTime":"09:27 EDT","volume":713,"amount":900.6706551,"timestamp":1786714061334,"change":0.01,"changeRate":0.007937,"amplitude":0.012063},"postHourTrading":{"tag":"盘后","latestPrice":1.4098,"preClose":1.4,"latestTime":"19:55 EDT","volume":30774,"amount":43458.8189,"timestamp":1786751727164,"change":0.0098,"changeRate":0.007,"amplitude":0.035643},"volumeRatio":2.0402693924866564},"requestUrl":"/m/hq/s/RNXT","defaultTab":"news","newsList":[{"id":"2659912609","title":"Cancer Diagnostics Firm Precipio's Q2 Revenue Rises, Adjusted Ebitda Turns Positive","url":"https://stock-news.laohu8.com/highlight/detail?id=2659912609","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659912609?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:10","pubTimestamp":1786738233,"startTime":"0","endTime":"0","summary":"Cancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positiveOverviewUS specialty cancer diagnostics firm's Q2 revenue rose 22% yr/yr to $7.0 mlnAdjusted EBITDA improved to $0.4 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0VE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","AKTS","BK4139","BK4196","CODX","BK4082","BK4568","PRPO","BK4148","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659463741","title":"Milestone Scientific Q2 Revenue Rises 22% on Medical Segment Growth, Reaffirms 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659463741","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659463741?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:42","pubTimestamp":1786707736,"startTime":"0","endTime":"0","summary":"Milestone Scientific Q2 revenue rises 22% on medical segment growth, reaffirms 2026 outlookOverviewMedical device maker's Q2 revenue rose 22% yr/yr, driven by dental and medical segment growthMedical ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4139","MLSS","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659116741","title":"Sensus Healthcare Q2 Revenue Misses Estimates as Unit Sales Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2659116741","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659116741?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:31","pubTimestamp":1786653086,"startTime":"0","endTime":"0","summary":"Sensus Healthcare Q2 revenue misses estimates as unit sales fallOverviewU.S. medical device maker's Q2 revenue fell sharply and missed analyst expectationsAdjusted EBITDA loss widened yr/yr, reflectin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A170:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SRTS","ATRA","BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167860","title":"CapsoVision Q2 Revenue Rises on CapsoCam Plus Capsules Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167860","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167860?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:17","pubTimestamp":1786652227,"startTime":"0","endTime":"0","summary":"CapsoVision Q2 revenue rises on CapsoCam Plus capsules salesOverviewUS capsule endoscopy firm's Q2 revenue rose 10% yr/yr to $3.6 mlnGross margin declined to 51% from 55% due to pricing pressure and h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A14S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","RNXT","BK4139","BK4539","CV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659028162","title":"Tenon Medical Q2 Revenue Jumps on Higher Surgical Procedure Volume","url":"https://stock-news.laohu8.com/highlight/detail?id=2659028162","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659028162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652143,"startTime":"0","endTime":"0","summary":"Tenon Medical Q2 revenue jumps on higher surgical procedure volumeOverviewUS medical device maker's Q2 revenue rose 127% yr/yr on higher surgical procedure volumeQ2 gross profit up 232% yr/yr, gross m","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A14N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","XTNT","TNON","BK4539","BK4139","RNXT","BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151392","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151392","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151392?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:40","pubTimestamp":1786621235,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on OptimizeRx (OPRX) and RenovoRx (RNXT) with bullish s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-298?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-298?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","OPRX","RNXT","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659562311","title":"Beyond Air Q1 Net Loss Slightly Widens, Reaffirms 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659562311","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659562311?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:13","pubTimestamp":1786619594,"startTime":"0","endTime":"0","summary":"Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlookOverviewUS medical device maker's Q1 revenue was flat yr/yr at $1.8 mlnCompany completed up to $30.1 mln financing to support commercial e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0GU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","LU0048573561.USD","XAIR","BK4007","BK4139","BK4564","VREX","RNXT","TDY","LU0742534661.SGD","BK4157","LU0251142724.SGD","BK4539","EYES","BK4082","LU0251131958.USD","BK4585","BK4588","BZZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659113378","title":"Sweden's RaySearch Q2 Order Intake Rises on Clinical Adoption","url":"https://stock-news.laohu8.com/highlight/detail?id=2659113378","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659113378?lang=en_us&edition=fundamental","pubTime":"2026-08-13 13:42","pubTimestamp":1786599764,"startTime":"0","endTime":"0","summary":"Sweden's RaySearch Q2 order intake rises on clinical adoptionOverviewSweden oncology software firm's Q2 net sales fell 11% yr/yr, organic growth at -8%Adjusted EPS for Q2 declined to SEK 0.57 from SEK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A06H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURA","BK4539","RNXT","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659868041","title":"RenovoRx Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659868041","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659868041?lang=en_us&edition=fundamental","pubTime":"2026-08-13 06:25","pubTimestamp":1786573545,"startTime":"0","endTime":"0","summary":"RenovoRx Inc reports results for the quarter ended June 30 - Earnings SummaryRenovoRx IncRNXT.OQreported a quarterly adjusted loss of 5 cents per share for the quarter ended June 30, higher than the s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4492B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900195","title":"Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900195","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900195?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:20","pubTimestamp":1786566051,"startTime":"0","endTime":"0","summary":"Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlookOverviewTargeted oncology device maker's Q2 2026 revenue rose 115% yr/yr to record $909,000Company raised full-year 2026 revenue gu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N44911Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4588","CANC","RNXT","BK4139","BK4505","BK4585","IMNM","LEGN","BK4539","MEMS","MEDI","BK4082","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907749","title":"RenovoRx Q2 Adj. EPS $(0.05) Beats $(0.07) Estimate, Sales $909.000K Beat $716.500K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907749","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907749?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:09","pubTimestamp":1786565357,"startTime":"0","endTime":"0","summary":"RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 37.5 percent increase over losses of $(0.08) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61158210/renovorx-q2-adj-eps-0-05-beats-0-07-estimate-sales-909-000k-beat-716-500k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"RenovoRx Q2 Adj. EPS $(0.05) Beats $(0.07) Estimate, Sales $909.000K Beat $716.500K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659758907","title":"RenovoRx Q2 Net Loss Holds at $2.91 Million; Revenue More than Doubled to $909,000 Year over Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2659758907","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659758907?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:07","pubTimestamp":1786565278,"startTime":"0","endTime":"0","summary":"RenovoRx Q2 net loss holds at $2.91 million; revenue more than doubled to $909,000 year over yearRenovoRx posted Q2 revenue of USD 909,000, up 61% sequentially, with gross margin of about 84%.Net loss","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLc6FgZ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","SG9999014013.SGD","BCDF","NDAQ","LU0314104364.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BGHQF748.EUR","BK4539","SG9999014039.USD","IE00BN0W2T93.GBP","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2W23.USD","RNXT","BK4112","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4585","BK4588","BK4139","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907214","title":"RenovoRx Q2 Net Income USD -2.911 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907214","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907214?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:06","pubTimestamp":1786565164,"startTime":"0","endTime":"0","summary":"BRIEF-RenovoRx Q2 Net Income USD -2.911 MillionAug 12 (Reuters) - RenovoRx Q2 operating expenses USD 4.115 million.Q2 basic EPS USD -0.06Q2 EPS USD -0.06","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXS0CXZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659163900","title":"RenovoRx - Raises Full-Year 2026 Revenue Guidance to $3.75 Mln-$4.25 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2659163900","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659163900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565105,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXS0CXZZ:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RNXT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907117","title":"RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907117","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907117?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565104,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA7X9CPG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658918880","title":"RenovoRx - Trial Completion Expected H1 2027; Top Line Data Expected H2 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2658918880","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658918880?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:30","pubTimestamp":1786451400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA74VDXJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNXT","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658544679","title":"RenovoRx Inc Expected to Post a Loss of 7 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658544679","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658544679?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:06","pubTimestamp":1786395965,"startTime":"0","endTime":"0","summary":"RenovoRx Inc <RNXT.OQ> expected to post a loss of7cents a share - Earnings PreviewRenovoRx IncRNXT.OQRNXT.Ois expected to  show a rise in quarterly revenue when it reports  results on August 12 for th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N44721C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNXT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657343006","title":"RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2657343006","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657343006?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:30","pubTimestamp":1786019400,"startTime":"0","endTime":"0","summary":"Case Marks First Use of RenovoCath in Sarcoma, Showing Real World Potential Beyond Pancreatic Cancer for Expansion of Localized Delivery of ChemotherapyMOUNTAIN VIEW, Calif., Aug.  06, 2026  (GLOBE NE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3340283/0/en/RenovoRx-Announces-First-Commercial-Clinical-Use-of-RenovoCath-in-Sarcoma-Patient-Treatment-Marking-Expansion-of-Targeted-Drug-Delivery-Device-to-Other-Solid-Tumors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4585","RNXT","LABU","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567271","title":"RenovoRx Highlights TAMP Platform in Upcoming Oncology Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567271","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567271?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:13","pubTimestamp":1785877980,"startTime":"0","endTime":"0","summary":"RenovoRx ( ($RNXT) ) has issued an update. On August 4, 2026, RenovoRx announced it would participate in a JonesTrading key opinion leader webinar ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renovorx-highlights-tamp-platform-in-upcoming-oncology-webinar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renovorx-highlights-tamp-platform-in-upcoming-oncology-webinar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNXT","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656652556","title":"RenovoRx Joins JonesTrading Webinar on TAMP Platform in Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2656652556","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656652556?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:32","pubTimestamp":1785846747,"startTime":"0","endTime":"0","summary":"RenovoRx joins JonesTrading webinar on TAMP platform in pancreatic cancerRenovoRx will join a JonesTrading virtual key opinion leader webinar on Aug. 13, 2026 at 1:30 p.m. ET.Discussion will center on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL3Zxtmy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BN0W2W23.USD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4588","IE00BN0W2T93.GBP","LU2095319765.USD","BK4112","NDAQ","SG9999014013.SGD","RNXT","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BK4139","BK4539","LU2210150020.SGD","SG9999014021.USD","BCDF","LU0314104364.USD","SG9999014039.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.renovorx.com;renovorx.com","stockEarnings":[{"period":"1week","weight":0.25},{"period":"1month","weight":0.6287},{"period":"3month","weight":0.7073},{"period":"6month","weight":0.5001},{"period":"1year","weight":0.129},{"period":"ytd","weight":0.6665}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0503},{"period":"6month","weight":0.1387},{"period":"1year","weight":0.2037},{"period":"ytd","weight":0.1385}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.049533},{"month":2,"riseRate":0.6,"avgChangeRate":0.102207},{"month":3,"riseRate":0.2,"avgChangeRate":-0.093103},{"month":4,"riseRate":0,"avgChangeRate":-0.163527},{"month":5,"riseRate":0.6,"avgChangeRate":0.050959},{"month":6,"riseRate":0.6,"avgChangeRate":0.043263},{"month":7,"riseRate":0.2,"avgChangeRate":-0.031811},{"month":8,"riseRate":0.4,"avgChangeRate":-0.003347},{"month":9,"riseRate":0.4,"avgChangeRate":-0.050074},{"month":10,"riseRate":0,"avgChangeRate":-0.120676},{"month":11,"riseRate":0.6,"avgChangeRate":0.028303},{"month":12,"riseRate":0.6,"avgChangeRate":0.479671}],"exchange":"NASDAQ","name":"RenovoRx Inc","nameEN":"RenovoRx Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RenovoRx Inc(RNXT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest RenovoRx Inc(RNXT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"RenovoRx Inc,RNXT,RenovoRx Inc股票,RenovoRx Inc股票老虎,RenovoRx Inc股票老虎国际,RenovoRx Inc行情,RenovoRx Inc股票行情,RenovoRx Inc股价,RenovoRx Inc股市,RenovoRx Inc股票价格,RenovoRx Inc股票交易,RenovoRx Inc股票购买,RenovoRx Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RenovoRx Inc(RNXT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest RenovoRx Inc(RNXT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction